Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AGEN1223 |
| Synonyms | |
| Therapy Description |
AGEN1223 is a specific antibody that binds to two antigens co-expressed on tumor-infiltrating Tregs (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AGEN1223 | AGEN-1223|AGEN 1223 | AGEN1223 is a specific antibody that binds to two antigens co-expressed on tumor-infiltrating Tregs (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04156100 | Phase I | AGEN1223 | A Study in Subjects With Advanced Solid Tumors | Terminated | USA | 0 |